Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
The Thyroid Gland01:23

The Thyroid Gland

4.2K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SMART Planning of Early-Stage Health Economic Decision Models for Mechanism-Based Precision Treatments in Rare Cancers: An Application and Tool Update.

PharmacoEconomics·2026
Same author

Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities.

International journal of molecular sciences·2026
Same author

Author reply on: Prolactin-adjusted inferior petrosal sinus sampling: Pituitary and ectopic adrenocorticotropic hormone-dependent Cushing syndrome.

Journal of neuroendocrinology·2026
Same author

Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.

European thyroid journal·2026
Same author

Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing's syndrome.

Journal of clinical & translational endocrinology·2026
Same author

Delivering cytokine mRNA to secondary lymphoid organs for robust cancer immunotherapy.

Research square·2026

Related Experiment Video

Updated: Aug 31, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

599

Differentiated thyroid carcinoma: An update.

Pepijn van Houten1, Romana T Netea-Maier1, Johannes W Smit1

  • 1Department of Internal Medicine, Division of Endocrinology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.

Best Practice & Research. Clinical Endocrinology & Metabolism
|August 24, 2022
PubMed
Summary
This summary is machine-generated.

Differentiated thyroid carcinoma (DTC) management is shifting towards personalized care. This review focuses on individualized risk assessment to reduce overtreatment for low-risk patients while ensuring appropriate care for those needing intensive treatment.

Keywords:
diagnosisdifferentiated thyroid carcinomafollicular thyroid carcinomapapillary thyroid carcinomarisk stratificationtreatment

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.9K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Related Experiment Videos

Last Updated: Aug 31, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

599
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

1.9K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K

Area of Science:

  • Endocrinology
  • Oncology
  • Cancer Research

Background:

  • Differentiated thyroid carcinoma (DTC) is the most common endocrine malignancy.
  • Increasing diagnostic scrutiny leads to a rise in detecting small, indolent DTC tumors, without impacting mortality rates.
  • Overdiagnosis and overtreatment pose risks and burdens to patients.

Purpose of the Study:

  • To review recent advancements in DTC diagnosis, staging, and management.
  • To emphasize a shift towards individualized, risk-based treatment strategies.
  • To guide clinicians in differentiating low-risk DTC from cases requiring intensive intervention.

Main Methods:

  • Literature review of recent developments in DTC management.
  • Analysis of evolving diagnostic and staging criteria.
  • Discussion of risk stratification models for DTC patients.

Main Results:

  • Current DTC management is critically appraising approaches to minimize patient burden.
  • A focus on individualized risk assessment is emerging for DTC.
  • Multidisciplinary collaboration is essential for optimal DTC management.

Conclusions:

  • The management of differentiated thyroid carcinoma is moving towards a more personalized, risk-stratified approach.
  • Reducing unnecessary interventions for low-risk DTC patients is a key objective.
  • Accurate identification of patients requiring intensive treatment and follow-up is crucial.